Regulatory Eli Lilly wins FDA approval for weight loss pill, tees up Novo rivalry Pharmaceutical TechnologyLilly's product, known under the brand name Foundayo, has a clear route to early blockbuster status.RegulatoryMetabolic & GLP-1Read full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Technology Lilly’s product, known under the brand name Foundayo, has a clear route to early blockbuster status. RegulatoryMetabolic & GLP-1Read full story Post navigation Previous: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26Next: ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity Related Stories Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026 Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026 Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
